-
Mashup Score: 11Managing the Challenges of Paying for Gene Therapies - ICER - 10 day(s) ago
This paper explains potential reforms to white bagging, brown bagging, and site of service policies. Learn more.
Source: icer.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8ICER Publishes Final Evidence Report on Treatment for Pulmonary Arterial Hypertension - ICER - 1 month(s) ago
Independent appraisal committee voted that sotatercept demonstrated a net health benefit when compared to background therapy; sotatercept would achieve common thresholds for cost-effectiveness if priced between $17,900 to $35,400 per year.
Source: icer.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5Institute for Clinical and Economic Review to Assess Treatments for Transthyretin Amyloidosis Cardiomyopathy - ICER - 2 month(s) ago
Report will be subject of Midwest CEPAC meeting in September 2024; Draft Scoping Document open to public comment until March 27, 2024
Source: icer.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12ICER Identifies Most Significant 2022 US Drug-Price Hikes Unsupported by New Clinical Evidence - ICER - 5 month(s) ago
Of 10 high-expenditure drugs that had substantial 2022 net price increases, eight were not supported by new clinical evidence; these increases accounted for $1.27 billion in additional costs over one year.
Source: icer.orgCategories: General Medicine News, Rare DiseaseTweet
Will be a while for #CardioTwitter but important concepts https://t.co/J2h9OJwaTX https://t.co/bYiX5Jr8va